Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 1;36(31):3162-3171.
doi: 10.1200/JCO.18.00407. Epub 2018 Sep 14.

Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients

Caroline Diorio  1 , Paula D Robinson  1 , Roland A Ammann  1 , Elio Castagnola  1 , Kelley Erickson  1 , Adam Esbenshade  1 , Brian T Fisher  1 , Gabrielle M Haeusler  1 , Susan Kuczynski  1 , Thomas Lehrnbecher  1 , Robert Phillips  1 , Sandra Cabral  1 , L Lee Dupuis  1 , Lillian Sung  1
Affiliations

Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients

Caroline Diorio et al. J Clin Oncol. .

Abstract

Purpose: The aim of this work was to develop a clinical practice guideline for the prevention and treatment of Clostridium difficile infection (CDI) in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation (HSCT) patients.

Methods: An international multidisciplinary panel of experts in pediatric oncology and infectious diseases with patient advocate representation was convened. We performed systematic reviews of randomized controlled trials for the prevention or treatment of CDI in any population and considered the directness of the evidence to children with cancer and pediatric HSCT patients. We used the Grading of Recommendations Assessment, Development, and Evaluation approach to generate recommendations.

Results: The panel made strong recommendations to administer either oral metronidazole or oral vancomycin for the initial treatment of nonsevere CDI and oral vancomycin for the initial treatment of severe CDI. Fidaxomicin may be considered in the setting of recurrent CDI. The panel suggested that probiotics not be routinely used for the prevention of CDI, and that monoclonal antibodies and probiotics not be routinely used for the treatment of CDI. A strong recommendation to not use fecal microbiota transplantation was made in this population. We identified key knowledge gaps and suggested directions for future research.

Conclusion: We present a guideline for the prevention and treatment of CDI in children and adolescents with cancer and pediatric HSCT patients. Future research should include randomized controlled trials that involve children with cancer and pediatric HSCT patients to improve the management of CDI in this population.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Flow diagram depicting study identification, selection, and reasons for exclusion.
See this image and copyright information in PMC

References

    1. Kelly CP, Pothoulakis C, LaMont JT: Clostridium difficile colitis. N Engl J Med 330:257-262, 1994 - PubMed
    1. Kim J, Shaklee JF, Smathers S, et al. : Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J 31:134-138, 2012 - PubMed
    1. de Blank P, Zaoutis T, Fisher B, et al. : Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 163:699-705.e1, 2013 - PMC - PubMed
    1. Gerding DN, Johnson S, Peterson LR, et al. : Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 16:459-477, 1995 - PubMed
    1. Palmore TN, Sohn S, Malak SF, et al. : Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 26:680-684, 2005 - PMC - PubMed